Outlook Therapeutics, Inc. (OTLK)

0.534 +0.03 (+5.53%) USD  |  NASDAQ  |  Jan 22, 13:19
More

Outlook Therapeutics Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for OTLK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Neogen Corp. Upgrade
CorMedix, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade